A few simple changes can dramatically reduce endophthalmitis

Article

Changes to perioperative management of cataract patients, including the use of disposable bimanual irrigation/aspiration handpieces, intracameral cefuroxime and povidone iodine wash can be effective in reducing the instances of endophthalmitis.

Changes to perioperative management of cataract patients, including the use of disposable bimanual irrigation/aspiration handpieces, intracameral cefuroxime and povidone iodine wash can be effective in reducing the instances of endophthalmitis, according to Richard Packer from the King Edward VII Hospital, Windsor, UK.

These changes were made following a cluster of postoperative endophthalmitis cases (nine in a four-month period). Since the introduction of the new regimes in May 2004, a total of 7,584 eyes were operated on for cataract at the hospital's Prince Charles Eye Unit. Twenty-four different surgeons, including six consultants, three associate specialists and 15 trainees carried out the surgery.

One culture-negative endophthalmitis was recorded, this recovered after intravitreal antibiotics to achieve an uncorrected vision of 6/9 by three weeks postoperatively. This represents an incidence of just 0.013% which is well below that reported in the relevant literature.

Dr Packard concluded that it only takes the implementation of a few simple measures to dramatically reduce the incidence of postoperative endophthalmitis.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.